FibroGen Soars 14% Higher: Outshines Market
(VIANEWS) – FibroGen stock price experienced an 14.14% surge on Wednesday, rebounding from Tuesday’s decline by rising 14.14% to EUR2.18. NASDAQ is up 0.81% but FibroGen’s stock is 92.56% below its 52-week high of EUR25.68. About FibroGen FibroGen Pharmaceuticals Inc is a biopharmaceutical company with the mission of discovering, developing and commercializing therapeutics to address…